A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading ->
Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms.  “How symptomatic a person […] Continue reading ->
The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries.  Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading ->
Europe reported 22 cases of Mpox in May, prompting the World Health Organization (WHO) to urge people in high risk communities to get vaccinated if possible.  WHO Europe director Dr Hans Kluge said that the virus is still in circulation, particularly affecting men who have sex with men. He added that people in high risk […] Continue reading ->
Eight social media influencers were selected earlier this week as winners of the UniteHealth Social Media Awards, showcasing individuals and organisations who used social media to strengthen collective understanding of the COVID-19 pandemic and evidence-based responses. The winners represent eight countries – nominees were recommended from more than 60 countries – and cover six categories […] Continue reading ->
For years, malaria has ruled mercilessly in certain regions of the world. Especially in Africa. Yet over the past decade, despite the absence of a malaria vaccine, one anti-malarial strategy sought to make a difference: more than 700 million doses of Seasonal Malaria Chemoprevention (SMC) were distributed to young children, globally.  The evidence is now […] Continue reading ->